10.1007 s11523-021-00826-1 Video Abstract.mp4 (88 MB)

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

media

posted on 2021-09-30, 09:17 authored by Adam M. Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Rachel M. Layman

Article full text

The above video abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s11523-021-00826-1

Usage metrics

Read the peer-reviewed publication

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

Targeted Oncology

Keywords

Breast Cancer Palbociclib CDK4/6 pathway CDK inhibitor

Licence

CC BY 4.0

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports